{
  "ptid_time": "052_S_5062_2013-01-25",
  "img_path": "/data/qiuhui/data/adni/images/052_S_5062/2013-01-25/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 28,198 mm³, 0.5% above the reference mean. With a Z-score of 0.01 (50.4th percentile), this represents normal volume ; hippocampal volume measures 5,848 mm³, 17.8% below the reference mean. With a Z-score of -1.63 (5.1th percentile), this represents moderate atrophy; whole brain volume measures 935,816 mm³, 4.0% below the reference mean. With a Z-score of -0.50 (30.8th percentile), this represents normal volume . ",
  "text_data": "Age is 71.0 years. Gender is Female. Education: 14 years. MMSE: 26.0. MoCA: 20.0. Logical Memory: 1.0. Laboratory findings: Vitamin B12: 1146.00 (profound elevated); Serum Glucose: 199.00 (profound elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.29 SUVR (moderate elevated); Amyloid beta: 542.40 pg/mL (mild reduced); Total tau: 739.30 pg/mL (profound elevated); Phosphorylated tau: 74.14 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "Reasoning: The hippocampal volume shows moderate atrophy (Z-score -1.63, 5.1th percentile), which is a strong biomarker for Alzheimer's pathology. Combined with elevated CSF biomarkers (Aβ reduction, elevated T-tau and P-tau) and moderate AV45 (amyloid PET) uptake, this suggests amyloid deposition and neurodegeneration. The MMSE (26) and MoCA (20) scores indicate mild cognitive impairment, with MoCA being more sensitive to early deficits.  \nDiagnosis: **MCI (likely due to Alzheimer's disease)**  \nConfidence: **High**  \n\n(Note: The presence of APOE4 further supports Alzheimer's risk, but the diagnosis is primarily based on biomarker and cognitive profiles.)",
  "timestamp": "2025-07-26T07:52:53.398433"
}